Navigation Links
Geneticist Francis Collins named first recipient of Inamori Ethics Prize at Case Western Reserve
Date:4/9/2008

CLEVELAND, OH - Francis S. Collins, M.D., Ph.D., a physician-geneticist and leader of the Human Genome Project, has been named recipient of the inaugural Inamori Ethics Prize from the Inamori International Center for Ethics and Excellence at Case Western Reserve University.

The Inamori Ethics Prize honors outstanding international ethical leaders. It is presented annually to an individual who has demonstrated exemplary ethical leadership and whose actions and influence have greatly improved the condition of humankind. The Inamori Ethics Prize carries with it a $25,000 cash award, intended to support the ongoing work of the prize recipient.

A ceremony recognizing Collins will be held in conjunction with an ethics and genetics symposium and lecture September 4, 2008 at Severance Hall, on the Case Western Reserve campus.

"Dr. Collins' reputation as a principled leader of the Human Genome Project and the understanding that the Human Genome Project holds enormous potential for the improvement of humankind, make him an ideal recipient of the first Inamori Ethics Prize," said Gregory L. Eastwood, M.D., director of the Inamori Center.

Noted for his landmark discoveries of disease genes, Collins serves as director of the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH). His laboratory is dedicated to researching both rare and common diseases and has discovered a number of important genes, including those responsible for cystic fibrosis, neurofibromatosis, Huntington's disease, adult onset diabetes and Hutchinson-Gilford progeria syndrome, a dramatic form of premature aging.

Collins led the multi-disciplinary, multi-institutional Human Genome Project, an international effort to map and sequence the three billion letters in the human DNA, offering the first complete view of the "human instruction book." With its ultimate goal of improving human health, many consider the project to be one of the most significant scientific undertakings of our time. All the groundbreaking data are now available to the scientific community without restrictions on access or use.

Since the project's culmination in 2003, Collins has directed NHGRI's efforts to ensure that the important genetic data contained within the book are translated into powerful tools and thoughtful strategies to advance biological knowledge and improve human health.

Collins aims to open avenues for genome research to benefit the health of people living in developing nations, building on his own experiences as a physician volunteer in a rural missionary hospital in Nigeria.

"Throughout his long and distinguished career, Dr. Collins has consistently emphasized the importance of ethical and legal issues in genetics, while at the same time working tirelessly to improving the lives of people worldwide," said Eastwood.

According to the NHGRI, its supported initiatives currently include efforts to map human genetic variation, to develop less costly sequencing technologies and to unravel the genetics of cancer and other common diseases. Following the precedent set by the Human Genome Project under Collins' leadership, these projects are committed to making their data rapidly and freely available to the worldwide scientific community.

His book, "The Language of God: A Scientist Presents Evidence for Belief" (Free Press, 2006), which broaches the interface between science and faith, spent several weeks on The New York Times bestseller's list.

Collins received a bachelor's degree in chemistry from the University of Virginia, a Ph.D. in physical chemistry from Yale University and his M.D. from the University of North Carolina. After an internal medicine residency at UNC and a genetics fellowship at Yale, he joined the faculty at the University of Michigan School of Medicine. He was appointed director of the National Center for Human Genome Research at NIH in 1993.

A member of the Institute of Medicine and the National Academy of Sciences, Collins has nearly 400 scientific publications in peer-reviewed journals, has received nine honorary degrees and in November 2007 was a recipient of the Presidential Medal of Freedom.


'/>"/>

Contact: Jason A. Tirotta
jason.tirotta@case.edu
216-368-6890
Case Western Reserve University
Source:Eurekalert  

Related biology news :

1. Columbia geneticists uncover new gene involved in determining hair texture and density in humans
2. Plant geneticists find veritas in vino
3. DHS Begins Collecting 10 Fingerprints From International Visitors at San Francisco International Airport
4. NJIT start-up company NeuroTrax named best in show
5. PNNLs Richard Smith named to prestigious Scientific American 50 list of outstanding leaders
6. UD named a regional research participant in National Children’s Study
7. CIC Again Named to Software Magazines Annual Prestigious Software 500 List
8. First diagnostic test for Alzheimers and Parkinsons disease on the horizon
9. Childrens Hospital leads projects to develop nations first heart assist devices for young children
10. First rule of evolution suggests that life is destined to become more complex
11. Scientists launch first comprehensive database of human oral microbiome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Geneticist Francis Collins named first recipient of Inamori Ethics Prize at Case Western Reserve
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
(Date:2/2/2017)... 2017  Central to its deep commitment to ... The Japan Prize Foundation today announced the laureates ... the envelope in their respective fields of Life ... are being recognized with the 2017 Japan Prize ... contribute to the advancement of science and technology, ...
(Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... SAN JOSE, Calif. , Feb. 23, 2017 ... an exclusive license for two key immunotherapy technologies ... The first technology provides a method to monitor ... therapy such as PD-L1 and CTLA-4.  The second ... detect if a patient is likely to have ...
(Date:2/23/2017)... ... February 23, 2017 , ... Baltimore ... multiple immunoassay-based threat detection technologies by researchers from the Pacific National Northwest ... detection technology was found to have the best level of detection (LOD) ...
(Date:2/23/2017)... , Feb. 23, 2017 Aviva ... tools, announced the acquisition of GenWay Biotech Incorporated, ... comprehensive service and product offering for both the ... will facilitate growth and enhance capabilities for both ... and ELISA assays will nicely complement ASB,s objective ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Park ... free AFM Luncheon for all SPIE attendees and Park customers ... just one block from the San Jose Convention Center. The luncheon will feature ...
Breaking Biology Technology: